Company Overview

Adaltis Inc. develops, manufactures, and markets in vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases, and measure human hormone responses. It offers diagnostic products, including automated diagnostic systems consisting of instruments, reagents, and software, which test a range of medical conditions. The company’s primary products include Eclectica, a closed random access instrument for immunoassay, clinical chemistry, specific protein, and electrolyte tests, as well as fertility/thyroid, diabetes, and oncology tests; and Nexgen Four/Personal Lab instruments, which are used in the testing of hepatitis, HIV, syphilis, TORCH, thyroid, an...

Adaltis Inc. develops, manufactures, and markets in vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases, and measure human hormone responses. It offers diagnostic products, including automated diagnostic systems consisting of instruments, reagents, and software, which test a range of medical conditions. The company’s primary products include Eclectica, a closed random access instrument for immunoassay, clinical chemistry, specific protein, and electrolyte tests, as well as fertility/thyroid, diabetes, and oncology tests; and Nexgen Four/Personal Lab instruments, which are used in the testing of hepatitis, HIV, syphilis, TORCH, thyroid, and other screening tests, including virology, steroids, fertility, autoimmunity, and tumor markers. It also offers a range of diagnostic related accessories and consumable healthcare products. In addition, the company provides installation, technical training, and technical support services. Adaltis offers its products through a network of distributors and agents to small and medium-sized laboratories and hospitals worldwide. The company was formerly known as BioChem ImmunoSystems Inc. and changed its name to Adaltis Inc. in May 2002. Adaltis Inc. was founded in 1987 and is headquartered in Montreal, Canada. On July 3, 2009, Adaltis, Inc was granted protection under the Companies' Creditors Arrangement Act.

Key Executives for Adaltis Inc.

Similar Private Companies By Industry

Recent Private Companies Transactions